Finance

Lists
Why is CTEV down 8,78%?
Dive Deeper
CTEV:NYSE
Claritev Corp
USD 19,74
-8,78%
(-1,90) 1D
5 Nov., 13:59:56 GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CTEV...
Open
USD 21,74
High
USD 21,74
Low
USD 19,25
Mkt. cap
334,54 m
Avg. vol.
214,75 k
Volume
138,24 k
52-wk high
USD 73,68
52-wk low
USD 11,50
EPS
-USD 17,00
Beta
1,05
Shares outstanding
16,95 m
No. of employees
3 k
Open
USD 21,74
High
USD 21,74
Low
USD 19,25
Mkt. cap
334,54 m
Avg. vol.
214,75 k
Volume
138,24 k
52-wk high
USD 73,68
52-wk low
USD 11,50
EPS
-USD 17,00
Beta
1,05
Shares outstanding
16,95 m
No. of employees
3 k
News stories
From web sources and news partners
About Claritev Corp
CEO-
Employees3 k
Founded1980
Headquarters-
SectorHealth Care
Industry-
Websiteclaritev.com
Analyst ratings
Based on 6 analysts giving stock ratings to CTEV in the past 3 months
Strong buy
Buy
5
Hold
1
Sell
0
12-month forecast
Based on 6 Wall Street analysts offering 12 month price targets for CTEV in the last 3 months.
Highest
Current USD 19,74
USD 73,00 (+269,81%)
Average
USD 45,83 (+132,17%)
Lowest
USD 30,00 (+51,98%)
Analyst
Recommendation
Action
Price target
Projected
Date
Glen Santangelo
Barclays
Buy
Maintained
USD 40,00
+102,6%
10/13/2026
Jessica Tassan
Piper Sandler
Buy
Reiterated
USD 73,00
+269,8%
08/18/2026
Stan Berenshteyn
Wells Fargo
Hold
Maintained
USD 30,00
+52%
08/12/2026
Richard Close
Canaccord Genuity
Buy
Reiterated
USD 43,00
+117,8%
08/10/2026
Daniel Grosslight
Citi
Buy
Maintained
USD 45,00
+128%
08/10/2026
Jason Cassorla
Guggenheim
Buy
Reiterated
USD 44,00
+122,9%
08/07/2026
Last report
07 Aug. 2026
Fiscal period
Q2 2026
-USD 2,94 / USD 1,33
-320,86%miss
Revenue / Est. (USD)
257,48 m / 244,81 m
+5,17%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
245,96 m
246,55 m
244,68 m
257,48 m
Cost of goods sold
62,06 m
70,09 m
69,08 m
67,67 m
Cost of revenue
62,06 m
70,09 m
69,08 m
67,67 m
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
48,01 m
40,64 m
46,04 m
46,14 m
Operating expense
159,95 m
152,37 m
157,13 m
156,84 m
Total operating expenses
222,01 m
222,46 m
226,21 m
224,51 m
Operating income
23,95 m
24,09 m
18,47 m
32,97 m
Other non operating income
-
-
-
-
EBT including unusual items
-93,36 m
-106,92 m
-92,72 m
-76,65 m
EBT excluding unusual items
-76,81 m
-75,04 m
-80,89 m
-67,09 m
Income tax expense
-23,61 m
-26,35 m
-19,16 m
-17,42 m
Effective tax rate
25,29%
24,64%
20,67%
22,73%
Other operating expenses
-
-
-
-
Net income
-69,75 m
-80,57 m
-73,56 m
-59,23 m
Net profit margin
-28,36%
-32,68%
-30,06%
-23,00%
Earnings per share
-
-3,19
-3,30
-2,94
Interest and investment income
471,00 k
279,00 k
182,00 k
195,00 k
Interest expense
-101,23 m
-99,41 m
-99,54 m
-100,25 m
Net interest expenses
-100,76 m
-99,13 m
-99,36 m
-100,06 m
Depreciation and amortization charges
25,97 m
25,89 m
25,18 m
24,80 m
EBITDA
135,89 m
135,83 m
129,56 m
143,67 m
Gain or loss from assets sale
196,00 k
8,68 m
-
57,00 k
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme